Strategic Wealth Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Strategic Wealth Partners's IBB Position: Q3 2026 in Review
Strategic Wealth Partners increased its iShares Biotechnology ETF (IBB) stake by 2.3% in Q3 2026, buying an estimated $2.81K and bringing the position to 627 shares worth $132K. The position accounts for 0.01% of the portfolio, ranked #300.
Strategic Wealth Partners first reported a position in IBB in Q3 2022 and has held it in 10 quarters since. The position peaked at $7.78M in Q1 2023. 1,031 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Strategic Wealth Partners held 627 shares of iShares Biotechnology ETF worth $132K as of Q3 2026.
- Strategic Wealth Partners bought 14 iShares Biotechnology ETF shares in Q3 2026, an estimated $2.81K.
- iShares Biotechnology ETF made up 0.01% of Strategic Wealth Partners's portfolio in Q3 2026, its #300 holding.
- Strategic Wealth Partners first reported a position in iShares Biotechnology ETF in Q3 2022 and has held it in 10 quarters since.
- Strategic Wealth Partners's iShares Biotechnology ETF position peaked at $7.78M in Q1 2023.
- 1,031 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Strategic Wealth Partners's 13F filing for Q3 2026, filed 13 Nov 2026.